DGNS Announces Private Placement, FOLK Set to Subscribe Shares

Jakarta, CNBC Indonesia - PT Diagnos Laboratorium Utama Tbk (DGNS) has announced plans for a private placement, also known as a capital increase without pre-emptive rights (PMTHMETD).

At the extraordinary general meeting of shareholders (RUPSLB) on 6 April 2026, shareholders approved the issuance of up to 125 million new shares with a par value of Rp25 each, equivalent to a maximum of 10% of the total issued and fully paid-up capital.

In this private placement, PT Multi Garam Utama Tbk (FOLK) will act as the subscriber for the new DGNS shares.

Management confirmed there is no affiliate relationship between DGNS and FOLK. The company will issue 95,348,500 new shares, representing 7.63% of the total issued and fully paid-up shares prior to the PMTHMETD.

The private placement price is set at Rp269 per share, resulting in a total fresh capital of Rp25,648,746,500 for the laboratory company.

All proceeds from the corporate action, after deducting other costs, will be fully allocated to business development for the group, including working capital, new outlet expansion, share and asset acquisitions, and equity investments in companies within relevant industries.

The private placement schedule is as follows:

• 25 May 2026: Application for registration of PMTHMETD shares.

• 26 May 2026: Announcement of PMTHMETD plan execution.

• 9 June 2026: Registration of PMTHMETD shares.

• 10 June 2026: Announcement of PMTHMETD results.